Search results

  1. New Diabetes Drug Poses Significant Heath Risks

    Invalid Link Removed Muraglitazar is a new drug developed to both lower blood glucose levels and improve blood lipids in patients with type 2 diabetes. On September 9, 2005, a US Food and Drug Administration (FDA) advisory panel strongly recommended approval of muraglitazar, and on October 18...
Back
Top